Association between serum uric acid levels and coronary flow reserve in hypertensive patients without concomitant risk factors

References

• Regoli F., Winston G. W. Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals. Toxicol Appl Pharmacol 1999; 156: 96–105
   PubMed Web of Science ®Google Scholar
• Freedman D. S., Williamson D. F., Gunter E. W., Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow‐up Study. Am J Epidemiol 1995; 141: 637–644
   PubMed Web of Science ®Google Scholar
• Alderman M. H. Uric acid and cardiovascular risk. Curr Opin Pharmacol 2002; 2: 126–130
   PubMed Web of Science ®Google Scholar
• Brand F. N., McGee D. L., Kannel W. B., Stokes J., Castelli W. P. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985; 121: 11–18
   PubMed Web of Science ®Google Scholar
• Fang J., Alderman M. H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow‐up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404–2410
   PubMed Web of Science ®Google Scholar
• Liese A. D., Hense H. W., Lowel H., Doring A., Tietze M., Keil U. Association of serum uric acid with all‐cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 1999; 10: 391–397
   PubMed Web of Science ®Google Scholar
• Alderman M. H., Cohen H., Madhavan S., Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999; 34: 144–150
   PubMed Web of Science ®Google Scholar
• Lehto S., Niskanen L., Ronnemaa T., Laakso M. Serum uric acid is a strong predictor of stroke in patients with non‐insulin‐dependent diabetes mellitus. Stroke 1998; 29: 635–639
   PubMed Web of Science ®Google Scholar
• Langlois M., De Bacquer D., Duprez D., De Buyzere M., Delanghe J., Blaton V. Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis 2003; 168: 163–168
   PubMed Web of Science ®Google Scholar
• Hoieggen A., Alderman M. H., Kjeldsen S. E., Julius S., Devereux R. B., De Faire U., , LIFE Study Group, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004; 65: 1041–1049
   PubMed Web of Science ®Google Scholar
• Johnson R. J., Kang D. H., Feig D., Kivlighn S., Kanellis J., Watanabe S., et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension 2003; 41: 1183–1190
   PubMed Web of Science ®Google Scholar
• Laine H., Raitakari O. T., Niinikoski H., Pitkanen O. P., Iida H., Viikari J., et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 1998; 32: 147–153
   PubMed Web of Science ®Google Scholar
• Schwartzkopff B., Motz W., Frenzel H., Vogt M., Knauer S., Strauer B. E. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88: 993–1003
   PubMed Web of Science ®Google Scholar
• Frohlich E. D. Fibrosis and ischemia: The real risks in hypertensive heart disease. Am J Hypertens 2001; 14: 194S–199S
   PubMed Web of Science ®Google Scholar
• Brilla C. G., Janicki J. S., Weber K. T. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991; 69: 107–115
   PubMed Web of Science ®Google Scholar
• Jennings G. L., Dilley R. J. Left ventricular remodelling impacts on coronary flow reserve in hypertensive patients: Is there a vascular mechanism?. J Hypertens 2002; 20: 1291–1293
   PubMed Web of Science ®Google Scholar
• Viazzi F., Parodi D., Leoncini G., Parodi A., Falqui V., Ratto E., et al. Serum uric acid and target organ damage in primary hypertension. Hypertension 2005; 45: 991–996
   PubMed Web of Science ®Google Scholar
• Erhardt J. G., Estes J. E., Pfeiffer C. M., Biesalski H. K., Craft N. E. Combined measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C‐reactive protein by an inexpensive, sensitive, and simple sandwich enzyme‐linked immunosorbent assay technique. J Nutr 2004; 134: 3127–3132
   PubMed Web of Science ®Google Scholar
• Devereux R. B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618
   PubMed Web of Science ®Google Scholar
• Erdogan D., Gullu H., Caliskan M., Yildirim I., Ulus T., Bilgi M., et al. Coronary flow reserve in dipper and non‐dipper hypertensive patients. Blood Press 2005; 14: 345–352
   PubMed Web of Science ®Google Scholar
• Caiati C., Montaldo C., Zedda N., Bina A., Iliceto S. New noninvasive method for coronary flow reserve assessment: Contrast‐enhanced transthoracic second harmonic echo Doppler. Circulation 1999; 99: 771–778
   PubMed Web of Science ®Google Scholar
• Galderisi M., Cicala S., Caso P., De Simone L., D'Errico A., Petrocelli A., et al. Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 2002; 90: 860–864
   PubMed Web of Science ®Google Scholar
• Fessel W. J. High uric acid as an indicator of cardiovascular disease. Independence from obesity. Am J Med 1980; 68: 401–404
   PubMed Web of Science ®Google Scholar
• Campion E. W., Glynn R. J., DeLabry L. O. Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. Am J Med 1987; 82: 421–426
   PubMedGoogle Scholar
• Ward H. J. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998; 352: 670–671
   PubMed Web of Science ®Google Scholar
• Messerli F. H., Frohlich E. D., Dreslinski G. R., Suarez D. H., Aristimuno G. G. Serum uric acid in essential hypertension: An indicator of renal vascular involvement. Ann Intern Med 1980; 93: 817–821
   PubMed Web of Science ®Google Scholar
• Verdecchia P., Schillaci G., Reboldi G., Santeusanio F., Porcellati C., Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000; 36: 1072–1078
   PubMed Web of Science ®Google Scholar
• Mattei P., Arzilli F., Giovannetti R., Penno G., Arrighi P., Taddei S., et al. Microalbuminuria and renal haemodynamics in essential hypertension. Eur J Clin Invest 1997; 27: 755–760
   PubMed Web of Science ®Google Scholar
• Khosla U. M., Zharikov S., Finch J. L., Nakagawa T., Roncal C., Mu W., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739–1742
   PubMed Web of Science ®Google Scholar
• Sanchez‐Lozada L. G., Tapia E., Santamaria J., Avila‐Casado C., Soto V., Nepomuceno T., et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 2005; 67: 237–247
   PubMed Web of Science ®Google Scholar
• Erdogan D., Gullu H., Caliskan M., Yildirim E., Bilgi M., Ulus T., et al. Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 2005; 59: 1276–1282
   PubMed Web of Science ®Google Scholar
• Caiati C., Zedda N., Montaldo C., Montisci R., Iliceto S. Contrast‐enhanced transthoracic second harmonic echo Doppler with adenosine: A noninvasive, rapid and effective method for coronary flow reserve assessment. J Am Coll Cardiol 1999; 34: 122–130
   PubMed Web of Science ®Google Scholar
• Saraste M., Koskenvuo J., Knuuti J., Toikka J., Laine H., Niemi P., et al. Coronary flow reserve: Measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol 2001; 21: 114–122
   PubMedGoogle Scholar
• Kozakova M., Palombo C., Pratali L., Pittella G., Galetta F., L'Abbate A. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension 1997; 29: 551–559
   PubMed Web of Science ®Google Scholar
• Opherk D., Mall G., Zebe H., Schwarz F., Weihe E., Manthey J., Kubler W. Reduction of coronary reserve: A mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984; 69: 1–7
   PubMed Web of Science ®Google Scholar
• Treasure C. B., Klein J. L., Vita J. A., Manoukian S. V., Renwick G. H., Selwyn A. P., et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium‐mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86–93
   PubMed Web of Science ®Google Scholar
• Wilson R. F., Laughlin D. E., Ackell P. H., Chilian W. M., Holida M. D., Hartley C. J., et al. Transluminal subselective measurement of coronary blood flow velocity and vasodilator reserve in man. Circulation 1985; 72: 82–92
   PubMed Web of Science ®Google Scholar
• Galderisi M., Cicala S., D'Errico A., de Divitiis O., de Simone G. Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease. J Hypertens 2004; 22: 2201–2208
   PubMed Web of Science ®Google Scholar